|
|
1.
|
Ledipasvir/sofosbuvir is effective and well tolerated in postkidney transplant patients with chronic hepatitis C virus. MedStar authors:
Year: 2017
Citation: - Clinical Transplantation. 31(5), 2017 May
Institution: - MedStar Washington Hospital Center
Medline publication type:
All authors: - Hassan M, Lalos A, Liriano-Ward L, Morales AL, Nair V, Sang M, Satoskar R, Schiano T, Smith C, Tierney A
|
|
|
2.
|
Podocyte effacement closely links to suPAR levels at time of posttransplantation focal segmental glomerulosclerosis occurrence and improves with therapy. MedStar authors:
Year: 2013
Citation: - Transplantation. 96(7):649-56, 2013 Oct 15.
Institution: - MedStar Union Memorial Hospital
Medline publication type:
- Journal Article
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
All authors: - Alachkar N, Arend LJ, Burke G, Estrella MM, Fornoni A, Jackson AM, Kakkad K, Rabb H, Racusen LC, Reiser J, Wei C
|
